Scopus
YÖKSİS ISSN Eşleşti
SJR Q4
Evaluation of Cytotoxic Properties of N,N'-bis[(1-aryl-3-heteroaryl)propylidene]-hydrazine dihydrochlorides
Pharmaceutical Chemistry Journal · Kasım 2020
Özet
N,N'-bis[(1-aryl-3-heteroaryl)propylidene]hydrazine dihydrochlorides, P1, P4 – P8, and R1 – R7, were assayed against human oral squamous cell carcinoma (HSC-2, HSC-3, HSC-4), human promyelocytic leukemia cell line (HL-60), and human normal oral cells (HGF, HPC, and HPLF) as non-tumor cells to evaluate their cytotoxic properties. Peplomycin was used as a reference compound. It was found that P- and R-series hydrazone compounds exhibited cytotoxicity in a range of 11 ± 0.68 – 300 ± 1.0 ± M. Compound P1 which is a non-substituted hydrazone containing piperidine ring and compound R2 which is a 4-methyl hydrazone derivative containing pyrrolidine ring showed the most potent cytotoxic activity. These hydrazone compounds may serve as promising candidates for further studies.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.
Evaluation of Cytotoxic Properties of N,N’xx-Bis[1-aryl-3-heteroaryl)propilidene]-hydrazine Dihydrochlorides
2020 ISSN: 0091-150X SCI-Expanded
Prof. Dr. KAAN KÜÇÜKOĞLU →
Evaluation of Mutagenic Activities of Antimicrobial Benzoxazole Derivatives
2022 ISSN: 0091-150X SCI-Expanded Q4
Dr. Öğr. Üyesi FATMA ZİLİFDAR FOTO →
Makale Bilgileri
Toplam Atıf
0 atıf
· Scopus
ISSN0091150X
Yayın TarihiKasım 2020
Cilt / Sayfa54 · 784-787
Scopus ID2-s2.0-85096318367
Kurumlar
Atatürk Üniversitesi
Erzurum Turkey
Meikai University
Sakado Japan
Selçuk Üniversitesi
Selçuklu Turkey
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Pharmaceutical Chemistry Journal
Q4
SJR Skoru0,211
H-Index44
YayıncıSpringer New York
ÜlkeUnited States
Drug Discovery (Q4)
Pharmacology (Q4)